tirzepatide nash for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the SYNERGY-NASH phase 2 trial Effect of tirzepatide versus insulin
Description
Compared to controls, bilirubin-treated mice exhibited reductions in body weight, blood glucose levels, total cholesterol (TC), leptin, total and direct bilirubin and increases in adiponectin and expression of SREBP-1, IR and PPAR mRNA
00070-5/asset/741f55c5-19b9-466e-8fd6-b3c5fb427911/main.assets/gr2_lrg.jpg)
Clean the skin with an alcohol swab and allow it to dry

Check out Mochi Health's 30 second TV commercial, 'GLP-1: Treating the Science'

Current FDA approva...
